Spots Global Cancer Trial Database for mastocytosis
Every month we try and update this database with for mastocytosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis | NCT05923372 | Mastocytosis, I... | 18 Years - | University Hospital, Toulouse | ||
| Characteristics of Mast Cells in Mastocytosis | NCT00001356 | Mastocytosis | - | National Institutes of Health Clinical Center (CC) | ||
| Natural History of Urticaria Pigmentosa in Children | NCT00467792 | Urticaria Pigme... | - 18 Years | Medical College of Wisconsin | ||
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | NCT00038675 | Chronic Myelomo... Chronic Myeloid... Polycythemia Ve... Hypereosinophil... Mastocytosis | Imatinib Mesyla... | - | M.D. Anderson Cancer Center | |
| Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation | NCT01266369 | Mastocytosis | masitinib | 18 Years - | AB Science | |
| Midostaurin in Indolent Systemic Mastocytosis | NCT01920204 | Indolent System... | Midostaurin, | 18 Years - | University Medical Center Groningen | |
| Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals | NCT00001760 | Atopic Dermatit... Healthy Mastocytosis | - | National Institutes of Health Clinical Center (CC) | ||
| Midostaurin in Indolent Systemic Mastocytosis | NCT01920204 | Indolent System... | Midostaurin, | 18 Years - | University Medical Center Groningen | |
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders | NCT00557895 | Allergy Asthma Allergic Rhinit... Mastocytosis Atopic Dermatit... Food Allergy | 3 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis | NCT00831974 | Mastocytosis | masitinib (AB10... masitinib (AB10... | 18 Years - | AB Science | |
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | NCT00038675 | Chronic Myelomo... Chronic Myeloid... Polycythemia Ve... Hypereosinophil... Mastocytosis | Imatinib Mesyla... | - | M.D. Anderson Cancer Center | |
| Mast Cell Activation Test in Allergic Disease | NCT03406325 | Asthma Mastocytosis Mast Cell Activ... Food Allergy Chronic Idiopat... Anaphylaxis Eczema | 18 Years - | Hong Kong Sanatorium & Hospital | ||
| Study of Mast Cell Precursors | NCT00001756 | Mastocytosis Healthy Volunte... | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | ||
| Molecular Mechanisms and Diagnosis of Mastocytosis | NCT00336076 | Mastocytosis | Collection of b... | - | University of Michigan | |
| Midostaurin in Indolent Systemic Mastocytosis | NCT01920204 | Indolent System... | Midostaurin, | 18 Years - | University Medical Center Groningen | |
| The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy | NCT02503800 | Hypersensitivit... Insect Bites an... Mastocytosis | 4 Years - 75 Years | Meir Medical Center | ||
| Treatment of Indolent Systemic Mastocytosis With PA101 | NCT02478957 | Mastocytosis Systemic Mastoc... Indolent System... | PA101 Placebo | 18 Years - 75 Years | Patara Pharma | |
| Myeloproliferative Neoplasms (MPNs) Patient Registry | NCT02760238 | Primary Myelofi... Polycythemia Ve... Essential Throm... Mastocytosis Leukemia, Myelo... Leukemia, Myelo... Chronic Eosinop... Myelodysplastic... Neoplasms Leukemia, Myelo... | Observational | - | University Health Network, Toronto | |
| Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Natural History of Urticaria Pigmentosa in Children | NCT00467792 | Urticaria Pigme... | - 18 Years | Medical College of Wisconsin | ||
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) | NCT00255346 | Acute Myeloid L... Myelodysplastic... Agnogenic Myelo... Myelofibrosis Hypereosinophil... Polycythemia Ve... Mastocytosis Leukemia, Myelo... | Dasatinib (BMS-... | 18 Years - | M.D. Anderson Cancer Center | |
| Myeloproliferative Neoplasms (MPNs) Patient Registry | NCT02760238 | Primary Myelofi... Polycythemia Ve... Essential Throm... Mastocytosis Leukemia, Myelo... Leukemia, Myelo... Chronic Eosinop... Myelodysplastic... Neoplasms Leukemia, Myelo... | Observational | - | University Health Network, Toronto | |
| Imatinib in KIT-negative Systemic Mastocytosis | NCT01297777 | Systemic Mastoc... | Imatinib Mesyla... | 18 Years - | Hospital Virgen de la Salud | |
| Mast Cell Activation Test in Allergic Disease | NCT03406325 | Asthma Mastocytosis Mast Cell Activ... Food Allergy Chronic Idiopat... Anaphylaxis Eczema | 18 Years - | Hong Kong Sanatorium & Hospital | ||
| Study of Factors Regulating Mast Cell Proliferation | NCT00044122 | Mastocytosis Monoclonal Bone Marrow Tryptase | 1 Day - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Cause and Natural Course of Pediatric-Onset Mastocytosis | NCT00050193 | Mastocytosis | - 21 Years | National Institutes of Health Clinical Center (CC) | ||
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) | NCT00255346 | Acute Myeloid L... Myelodysplastic... Agnogenic Myelo... Myelofibrosis Hypereosinophil... Polycythemia Ve... Mastocytosis Leukemia, Myelo... | Dasatinib (BMS-... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Factors Regulating Mast Cell Proliferation | NCT00044122 | Mastocytosis Monoclonal Bone Marrow Tryptase | 1 Day - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Study of Factors Regulating Mast Cell Proliferation | NCT00044122 | Mastocytosis Monoclonal Bone Marrow Tryptase | 1 Day - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Cromoglicate in Mastocytosis | NCT01701843 | Mastocytosis | Cromoglicate Placebo | 18 Years - 70 Years | LEO Pharma | |
| Pregnancy and Medically Assisted Conception in Rare Diseases | NCT02450396 | Rheumatoid Arth... Spondyloarthrit... Psoriatic Arthr... Systemic Lupus ... Antiphospholipi... Sjogren Syndrom... Scleroderma Myositis Vasculitis Mastocytosis Various Autoimm... | - | Assistance Publique - Hôpitaux de Paris | ||
| Study of Cellular Heterogeneity in Patients With Mastocytosis | NCT06432556 | Mastocytosis | scRNAseq two Skin biopsi... one Skin biopsi... | 18 Years - | University Hospital, Toulouse | |
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) | NCT00255346 | Acute Myeloid L... Myelodysplastic... Agnogenic Myelo... Myelofibrosis Hypereosinophil... Polycythemia Ve... Mastocytosis Leukemia, Myelo... | Dasatinib (BMS-... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 | NCT02808793 | Indolent System... | AK002 | 18 Years - 65 Years | Allakos Inc. | |
| Cromoglicate in Mastocytosis | NCT01701843 | Mastocytosis | Cromoglicate Placebo | 18 Years - 70 Years | LEO Pharma | |
| Treatment of Indolent Systemic Mastocytosis With PA101 | NCT02478957 | Mastocytosis Systemic Mastoc... Indolent System... | PA101 Placebo | 18 Years - 75 Years | Patara Pharma | |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment | NCT04333108 | Indolent System... | Masitinib Placebo Best Supportive... | 18 Years - 75 Years | AB Science | |
| Mast Cell Connect: A Registry for Patients With Mastocytosis | NCT02620254 | Mastocytosis | - | Blueprint Medicines Corporation | ||
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders | NCT00557895 | Allergy Asthma Allergic Rhinit... Mastocytosis Atopic Dermatit... Food Allergy | 3 Years - 80 Years | National Institutes of Health Clinical Center (CC) | ||
| Mast Cell Connect: A Registry for Patients With Mastocytosis | NCT02620254 | Mastocytosis | - | Blueprint Medicines Corporation | ||
| Midostaurin in Indolent Systemic Mastocytosis | NCT01920204 | Indolent System... | Midostaurin, | 18 Years - | University Medical Center Groningen | |
| Cause and Natural Course of Pediatric-Onset Mastocytosis | NCT00050193 | Mastocytosis | - 21 Years | National Institutes of Health Clinical Center (CC) | ||
| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | NCT04996875 | Advanced System... SM With an Asso... Mast Cell Leuke... Aggressive Syst... | bezuclastinib | 18 Years - | Cogent Biosciences, Inc. | |
| Myeloproliferative Neoplasms (MPNs) Patient Registry | NCT02760238 | Primary Myelofi... Polycythemia Ve... Essential Throm... Mastocytosis Leukemia, Myelo... Leukemia, Myelo... Chronic Eosinop... Myelodysplastic... Neoplasms Leukemia, Myelo... | Observational | - | University Health Network, Toronto | |
| Angioedema Biomarker Research Study | NCT06210698 | Angioedema Angioedemas, He... Urticaria Mastocytosis ACE Inhibitor-I... C1 Inhibitor De... Systemic Mastoc... Indolent System... | Venipuncture | 12 Years - 75 Years | Foundation For Rare Disease Research | |
| Study on Mastocytosis for Rupatadine Treatment | NCT01481909 | Mastocytosis | Rupatadin | 18 Years - 65 Years | Charite University, Berlin, Germany | |
| Imatinib in KIT-negative Systemic Mastocytosis | NCT01297777 | Systemic Mastoc... | Imatinib Mesyla... | 18 Years - | Hospital Virgen de la Salud | |
| The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients | NCT01333293 | Mastocytosis | injections | 18 Years - 70 Years | University of Zurich | |
| Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis | NCT05923372 | Mastocytosis, I... | 18 Years - | University Hospital, Toulouse | ||
| Pregnancy and Medically Assisted Conception in Rare Diseases | NCT02450396 | Rheumatoid Arth... Spondyloarthrit... Psoriatic Arthr... Systemic Lupus ... Antiphospholipi... Sjogren Syndrom... Scleroderma Myositis Vasculitis Mastocytosis Various Autoimm... | - | Assistance Publique - Hôpitaux de Paris | ||
| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis | NCT05186753 | SSM Mastocytosis, I... Mastocytosis, S... Mastocytosis | Bezuclastinib T... Bezuclastinib T... Placebo Tablets | 18 Years - | Cogent Biosciences, Inc. | |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis | NCT00814073 | Indolent System... | Masitinib Placebo Best Supportive... | 18 Years - 75 Years | AB Science |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
